The biosynthesis and biotechnological production of Rosmarinic acid, a phenolic ester that is widespread in the plant kingdom, has been widely investigated. This compound has shown many remarkable biological and pharmacological activities, which have led to its pharmaceutical and analytical development, as well as clinical studies, which are summarized and analyzed here for the first time. This review compiles data from the Pubmed, Scopus, Scifinder, Web Of Science, and Science Direct databases published between 1990 and 2015, restricting the search to works with the keywords "Rosmarinic acid" in the title. The initial search identified more than 800 articles; after an initial screening and removal of duplicate works, the search was further refined, resulting in approximately 300 articles that were scrutinized and comprise this review. The articles were organized to describe extraction and isolation, analytical methods, pharmaceutical development, and biological and pharmacological activities [divided into nonclinical (in vitro, in vivo) and clinical studies], pharmacokinetic studies, and stability studies.
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ultra performance liquid chromatography UV-Vis: ultraviolet-visible spectroscopy highest RA yield [53] . The same plant leaves treated with supercritical fluid-CO 2 at 5000 psi and 40, 60, and 80°C showed that extraction at 60°C furnished the highest amount of RA [54] . However, comparative studies on rosemary leaves using SFE, the hydrodistillation method, and solvent extraction with different solvents showed that the RA content was highest in the solvent extraction with ethanol [55] . Again in rosemary leaves, PLE using water and ethanol as solvents, compared to SFE using neat CO 2 and supercritical CO 2 modified with ethanol, showed that PLE using ethanol at temperature (150°C) produced the highest RA yield [56] . From these comparative studies, it cannot be concluded that there is an ideal solvent or method to obtain RA, as it depends on the combination of chosen parameters.
To provide one-step isolation and purification of RA from S. miltiorrhiza, an online adsorption chromatography-countercurrent chromatography was carried out after UAE, adsorbing the plant extract on the resin and immediately submitting it to high-speed countercurrent chromatography (HSCCC), which led to the isolation of RA with a purity of about 88% [12] . A template-assisted process using the supramolecular technique has also been used to extract RA from P. frutescens leaves. A P. frutescens extract, separated by supramolecular formation using flavocommelin and magnesium acetate aqueous solution followed by solvent extraction (ethyl acetate and water), yielded RA with 62.9 ± 4.5 % purity [58] . Analytical techniques used to determine RA include capillary electrophoresis [59] , electromechanical [60] , spectroscopical [61] [62] [63] [64] , and chromatographic methods [65] [66] [67] [68] [69] [70] [71] . Some unusual electrochemical techniques have been developed, such as that reported by Franzoi et al. [72] , which uses a biosensor based on laccase from the fungus Aspergillus oryzae and the ionic liquid 1-n-butyl-3-methylimidazolium hexafluorophosphate (BMIPF6) to determine RA in M. officinalis by square wave voltammetry. Additionally, a synthetic heterodinuclear Fe(III)Zn (II) complex, a biomimetic complex of purple acid phosphatases, has also shown to be effective in determining RA in plant extracts [60] . The amount of RA determined by these techniques was in accordance with capillary electrophoresis data. Another electrochemical technique using dual-channel coulometric detection coupled with liquid chromatography has also been used to quantify RA in Prunella vulgaris L. (Lamiaceae), animal feed, and pig plasma, with minimum preseparation steps, offering good selectivity and sensitivity [69] . Standard chromatographic techniques are the most frequent form of analysis used in the determination of RA. These can be grouped into TLC densitometry or HPTLC, and LC methods. TLC/ HPTLC methods are the most accessible ones, but provide variable quantitative results since some methods possess methodological weakness. For example, integrated in the development process of a new method, a validation step is mandatory to demonstrate its reliability and the suitability. These methods used diverse stationary phases, such as normal silica gel [65, [73] [74] [75] [76] [77] and chemically modified silica gel with amino, cyano, or octadecyl groups [70, 78, 79] . Using densitometry, Janicsak et al. [76] showed the RA content in some species of Lamiaceae ranging from 0.01 to 9.30 mg/g. . Moreover, LC/tandem mass spectrometry has also been exploited to determine RA and some other components in beagle dog plasma [82] during pharmacokinetic studies. Here, the deprotonated molecule [M -H] − was also used, since the sensitivity in the negative mode was higher than that in the positive mode. The limit of detection was found to be 1.0 ng/mL. Meanwhile, an HPLC-DAD-DPPH method has been used for online detection of the radical scavenging activity of RA [80] . After HPLC separation and UV detection at 280 nm, the analytes reacted post-column with the DPPH at a concentration of 50 mg/mL in methanol. Trute and Nahrstedt [83] developed a laborious two-step derivatization gas chromatography method to analyze RA enantiomers. Regarding spectroscopic methods, a spectrophotometric analysis developed by Oztürk et al. [61] , based on the complexation of RA with zirconium ions, was used for the quantification of RA in 11 Salvia species. Infrared spectroscopy has also been used to quantify RA in the Lamiaceae family [62, 64] . While Stehfest et al. [64] used the first derivative of the spectral region for quantification purposes, Saltas et al. [62] used the second derivative of the spectral region 1344-806 cm −1 . NMR spectroscopy has also been used to identify and quantify RA in methanol and ethanol extracts of plant species of the Lamiaceae family [63, 84] , based on variable-temperature two-dimensional 1 H-1 H double quantum filter correlation spectroscopy (DQF-COSY), 1 H-13 C heteronuclear multiple-quantum coherence (HMQC), and 1 H-13 C heteronuclear multiple-bond correlation (HMBC) gradient NMR spectroscopy.
Pharmacological and Biological Activities

!
The pharmacological and biological activities of RA and RA-containing plant extracts have received considerable attention. Many scientific reports and patents have explored these properties, ranging in complexity from in vitro to clinical studies. The exceptional antioxidant activity of RA, in parallel with the effects on cell signalling pathways and gene expression, contributes to the majority of the biological properties and technological applications covered by this review [28, [85] [86] [87] [88] [89] [90] [91] . As a result, RA antioxidant and pro-oxidant profiles [92, 93] have been comprehensively studied, through multiple assays [93] [94] [95] [96] [97] [98] [99] [100] [101] . The four phenolic hydrogens underwrite its ability to modulate free radical scavenging, in combination with two catechol moieties that provide the suitable polarity for RA to penetrate the lipid bilayers and protect them against oxidation without disturbing their structure [94, 96] . Electrochemical investigations have revealed that the first oxidation step is associated with the caffeic acid moiety, whereas the second oxidation step corresponds to the oxidation of the 3,4-dihydroxyphenyl lactic acid residue [94] . Due to the combination of these structural features, the antioxidant potential of RA is higher than that of the other hydroxycinnamic acid derivatives [96, [102] [103] [104] .
Besides the antioxidant potential, RA has been reported to present a multitude of pharmacological and biological activities. An in-depth description of each would be beyond the scope of this review, but a compilation and analysis of these reports is presented below (studies reporting solely extracts results were not included, unless otherwise stated). It is divided into three sections: in vitro, in vivo, and clinical studies.
In vitro studies
RA exhibits a wide collection of biological activities in vitro, including antioxidant, anti-inflammatory, antimutagenic, antigenotoxic, cytotoxic, antimetastatic, antiangiogenic, neuroprotective, antimicrobial, immunomodulatory, melanogenic, and antivenom effects. The array of active concentrations reported in the studies covers different magnitudes, which raises concerns about specificity. Additionally, active concentrations in the milimolar, or even high micromolar range, are unlikely to translate into clinical effects due to limitations related to plasma levels and biodistribution in humans (see section "Pharmacokinetics in Humans"). l " Table 2 provides a non-exhaustive list of in vitro findings obtained with RA. Studies that focus on the technological application of RA have reported that this phenolic acid is a good bioprotective agent against fungal infections in crops [105] , and a good candidate for partial monolignol substitution via bioengineering approaches, aiming at more efficient utilization of plant fibers for biofuels or livestock production [106] . Pharmacokinetic studies of RA using in vitro models have also been conducted by some research groups. Qiang et al. compared the permeability and phase II biotransformation of RA as a pure compound and also in herbal extracts using human intestinal epithelial Caco-2 cell monolayers. The apparent permeability coefficient (P app ) obtained for RA was 0.2 × 10 − 6 cm/s, indicating a low permeability profile [107] . In agreement, Konishi and Kobayashi reported that in vitro intestinal absorption of RA was rather low.
The majority of RA loaded on the apical side of Caco-2 cells was not transported, and the permeation occurred mainly via paracellular diffusion [108] . Moreover, RA appeared to be unsusceptible to chemical and enzymatic hydrolysis in Caco-2 cells and gastrointestinal models [108, 109] . Conversely, the addition of Lactobacillus johnsonii cells to the rosemary extract resulted in a substantial hydrolysis of RA [109] . Taken together, these results suggest that RA is further metabolized and degraded by gut microflora, in accordance with in vivo studies (see "Pharmacokinetics in Animals" section). RA metabolites are then efficiently absorbed and distributed by the monocarboxylic acid transporter within the body [ In vivo studies By compiling the in vivo studies, it was found that numerous biological studies corroborate the in vitro hypothesis. A significant prevalence of anti-inflammatory, antitumoral, and tissue damage prevention studies was also found. These reports highlight, once again, antioxidant and radical scavenging activities as key factors in the in vivo outcomes reported for RA.
The search for antitumoral compounds also included investigations of RA against different types of cancer [113] [114] [115] [116] [117] . Karmokar et al. showed that chronic consumption of RA (0.3 % w/w chow supplementation) for 8 weeks inhibited colon carcinogenesis in mice, and produced quantifiable levels of the parent compound in the plasma and the intestinal tract [118] . Additionally, RA suppressed retinal neovascularization [119] , and exhibited transcorneal penetration when the RA-containing polyherbal formulation was instilled into rabbit eyes [120] .
No increase was found in the frequency of micronuclei in mice treated orally with 50-200 mg/kg of RA, indicating that RA does not affect chromosomal integrity [121] . In fact, RA showed antimutagenic effects, protecting animals against doxorubicin [121] , ethanol [122] , and γ ray-induced DNA damage [123] , assessed by the comet and micronucleus assays using murine models. Studies exploring the anti-inflammatory activity of RA are also frequent [124] [125] [126] [127] . Youn et al. showed that RA (daily intraperitoneal injections, 50 mg/kg) suppressed synovitis in a murine collagen induced arthritis model [128] , while other groups reported the inhibition of allergic inflammatory reactions [129] and airway inflammation [130, 131] as well as atopic dermatitis [132, 133] . Jiang et al. reported that RA, administered intravenously (25 and 50 mg/kg), either alone or in combination with imipenem, protected rats against experimental sepsis by decreasing local and systemic levels of an extensive spectrum of inflammatory mediators [134] . Additionally, oral administration of RA (2 mg/ body for 3 days) inhibited diesel exhaust particle-induced lung injury in mice by reducing the expression of proinflammatory molecules and antioxidative activities [135] .
In regard to anti-infective potential, RA presented in vivo antiviral activity against the Japanese encephalitis virus, a member of the Flaviviruses family [136] . At 8 to 9 days postinfection, the mortality of mice treated intraperitoneally twice daily (25 mg/ kg) was reduced in comparison to untreated animals. This effect was mediated by decreased viral loads, and also by reduced levels of proinflammatory cytokines [136] . RA was also shown to be immunosuppressant, improving skin [137] and islet allograft survivals in murine models [138] . Antihemorrhagic, antithrombotic, and antiplatelet effects, along with the direct neutralization of multiple snake venoms and fish toxins, have also been reported for RA or RA-containing extracts [139] [140] [141] [142] [143] [144] [145] [146] [147] , corroborating for a potentially beneficial role of RA for the treatment of poisoning accidents, already described in the in vitro section (l " Table 2 ). Protective effects of RA in tissue or organs have been demonstrated. Domitrovic et al. showed that oral treatment with RA (1-5 mg/kg) for two consecutive days improved cisplatin-induced kidney injury in mice by inhibiting oxidative stress, inflammation (TNF-α and NF-κB), and apoptosis [148] . Other groups reported similar profiles [149] [150] [151] [152] , i.e., inhibition of diabetes-related renal damage [153] or inhibition of gentamicin sulphate-induced renal oxidative damage in rats treated orally with 50 mg/kg for 12 days [154, 155] . Also, memory protective effects of RA in an Alzheimerʼs model (β-amyloid neurotoxicity) was attributed to the radical scavenging potential of the molecule [156] . Cardioprotection [157, 158] , inhibition of endothelial tissue damage [159] , and reduction of multiple organ failure in thermal injury [160] were linked to the antioxidant and anti-inflammatory effects of RA in vivo. Liver protection effects against cholestatic fibrosis, ischemia-reperfusion injury, CCl 4 , and lipopolysaccharide-induced damage were also reported at oral doses ranging from 2.5 to 50 mg/kg [160] [161] [162] [163] [164] [165] . The neuroprotective effect of RA was studied in animal models of central nervous system diseases. Mushtaq et al. showed that oral treatment with RA (10 mg/kg) for 21 days significantly reduced the level of lipid peroxidation in multiple areas of the brain in diabetic rats, together with modulation of cholinergic neurotransmission [166] . At doses higher than 50 mg/kg, RA produced a significant anti-inflammatory effect in rats submitted to an experimental ischemic diabetic stroke model [167] . In a Parkinsonʼs disease model in mice, 6-OHDA-induced degeneration of the nigrostriatal dopaminergic system was reversed by 21 days of oral treatment with RA at 20 mg/kg [168] . A number of groups reported that administration of RA (orally or intraperitoneally) alleviated stress symptoms [169] [170] [171] [172] [173] and depressive-like behaviors [174] [175] [176] , and produced anxiolytic-like effects, without exerting locomotor alterations or DNA damage in brain tissue [177] . Additionally, subchronic oral RA treatment of mice (up to 3 weeks) has a cognitive-enhancing effect [178] , and, in a model of Amyotrophic lateral sclerosis, RA administered intraperitoneally (0.13 mg/kg, twice a week) significantly delayed motor dysfunction, attenuated motor neuron degeneration, and improved clinical outcomes and lifespan [179] .
Finally, an unusual preclinical study in a Rhesus monkey model was conducted to determine the effect of the topical application of RA on the progression of plaque-induced gingivitis. Six young adult (4-6 years) male Rhesus monkeys (Macaca mulatta) randomly assigned to 3 groups of 2 each (A, B and C) received a topical application of vehicle alone, the drug ebselen (1%), and RA (5%) twice weekly for two weeks. To promote plaque retention, the chow was softened with water prior to feeding. Clinical evidence of gingivitis (erythema, edema) was apparent after 2-3 days, with established gingivitis (GI = 2) apparent in all animals after one week. Based on these preliminary studies, the authors concluded that at least in the short term, ebselen and RA are effective at reducing both gingival inflammation and plaque accumulation when topically applied [180] .
Clinical studies with rosmarinic acid containing extracts
As a widespread metabolite, several traditional plants have been clinically studied using RA as a chemical marker or as an active compound. Different clinical protocols designed to assess the anti-inflammatory effects and the antioxidant potential of plants containing RA have been employed. Initially, links between oxidative stress and adverse health effects have been suggested; for example, Ranjbar et al. [181] investigated the antioxidant influence of an Echium amoenum Fisch & C. A. Mey (Boraginaceae) decoction in healthy volunteers using a cross-sectional before/after clinical trial. The authors considered E. amoenum, one of the most important medicinal plants in Iranian traditional medicine (despite its hepatotoxic pyrrolizidine alkaloids [182] ) to be a rich source of RA and flavonoids. They randomly selected thirty-eight volunteers (18-25 years old), students at Arak University of Medical Sciences, who were interviewed by a specialized physician before receiving the E. amoenum flower decoction (7 mg/kg) twice daily (morning and evening) for 2 weeks. The authors found a significant decrease (p < 0.05) in lipid peroxidation (24.65 ± 11.33 to 19.05 ± 9.7 nmol/mL), an increase in total blood antioxidant capacity (p < 0.05; 1.46 ± 0.51 to 1.70 ± 0.36 mmol/mL), as well as an increase (p < 0.001) in total thiol molecules (0.49 ± 0.11 to 0.56 ± 0.12 mmol), after administration of the decoction. In their view, this is the mechanism by which RA and antioxidants protect the human body from various diseases. This study has a ma-jor limitation, as the authors administered a decoction that was not standardized in terms of RA content. With a similar objective, a crossover randomized controlled trial study [183] detected, by means of LC-quadrupole time-of-flight, phenolic acids (among them RA) and aromatic compounds in human plasma 24 h after consumption of a blueberry drink containing 766 mg total polyphenols by healthy volunteers (n = 10). The primary outcome was the measure of flow-mediated dilation. Flow-mediated dilation increased after 1 h of consumption and then plateaued. According to the authors, increases in flow-mediated dilation were closely linked to increases in circulating phenolic metabolites and decreases in neutrophil NADPH oxidase activity at 1-2 and 6 h. The authors reported limitations when interpreting the trial datasets, such as the short time frame, causality, and the population studied. Also focusing on antioxidant foods, a study was conducted with 11 healthy volunteers consuming two kinds of burger meatseasoned or unseasoned with a spice blend [184] . The production of malondialdehyde in the burgers and the malondialdehyde concentration in plasma and urine after ingestion were measured, since the formation of malondialdehyde has implications for atherogenesis and carcinogenesis [185] . RA from oregano was monitored to assess the effect of cooking on the spice antioxidant content. Forty percent (19 mg) of the rosmarinic acid added remained in the spiced burger after cooking. There was a 71 % reduction in the malondialdehyde concentration (0.52 ± 0.02 µmol/ 250 g) in the meat of the spiced burgers compared with the malondialdehyde concentration (1.79 ± 0.17 µmol/250 g) in the meat of the control burgers. The plasma malondialdehyde concentration increased significantly in the control burger group compared to the baseline (p = 0.026). There was a significant time-trend difference (p = 0.013) between the two groups. Urinary malondialdehyde concentrations (µmol/g creatinine) decreased by 49 % (p = 0.021) in subjects consuming the spiced burgers compared with subjects consuming the control burgers. The authors concluded that cooking hamburgers with a polyphenol-rich spice mixture can significantly decrease the concentration of malondialdehyde, suggesting potential health benefits for atherogenesis and carcinogenesis. Nasal polyposis is a mucosal inflammatory disease that was investigated in a double-blind placebo-controlled crossover trial using 1 cup of a mint tea high in RA (about 300 mg) versus 1 cup of a mint tea low in RA (about 20 mg per day). Each treatment period lasted 4 weeks, separated by a 4-week washout period, and the first treatment followed a 2-week baseline period. Twentytwo adult subjects completed the study, and the authors found no statistically significant difference between the treatments in nasal stuffiness, as recorded on daily diary cards, in peak nasal inspiratory flows measured twice daily, or in patientsʼ global assessment (including ability to smell or sleep) performed at the end of each treatment period [186] . A more recent randomized, parallel-arm, double-blind study (meeting the CONSORT statement) investigated the effect of RA in the management of knee osteoarthritis symptoms using tea brewed from the high-RA spearmint plant (130-150 mg of RA per cup, n = 22) and a commercially available spearmint tea (ca 13 mg of RA, n = 24). The subjects were instructed to consume two cups of tea per day from a 300-mL study mug provided to them, for a 16-week period. The outcome was measured using the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) pain score, which is a validated, standardized 24-item questionnaire that assesses pain, disability, and joint stiffness as-sociated with osteoarthritis. The study allowed the subjects to maintain their normal pain medication in order to explore the potential of the high-RA tea as a complementary therapy. The authors concluded that individuals who consumed 600 mL of high-RA spearmint tea daily showed a significant decrease in pain scores from weeks 0 to 16, inferring that adults with knee osteoarthritis may benefit from the inclusion of high-RA spearmint tea in their daily diet. No serious adverse events were reported during the study [187] .
Clinical studies with isolated rosmarinic acid RA was clinically investigated in atopical dermatitis due to its in vitro and in vivo anti-inflammatory effects, such as its ability to block complement fixation, inhibit lipoxygenase and cyclooxygenase activity, and suppress IKK-β downstream signaling in the TNF-α-induced upregulation of CCL11. Oil-in-water cream with or without rosmarinic acid (0.3 %) was applied to the elbow flexures of 21 subjects (14 women and seven men; 15.1 ± 3.1 years) twice daily, for 4 and 8 weeks. The subjects were clinically graded as having moderate atopic dermatitis, according to the guidelines of the SCORAD index. The evaluation methods included clinical assessments (SCORAD), instrumental assessments (TEWL) and self-assessments by questionnaire. The authors reported that RA cream caused no reactions in the patch test on patient, suggesting that RA can safely be applied to human skin. After treatment with RA, the authors observed a statistically significant reduction in the SCORAD score, a decrease in itching, and a decrease in TEWL, suggesting that RA is a possible atopical dermatitis-mitigating agent [188] . Likewise, considering that RA is a strong anti-inflammatory agent in several animal models, a 21-day randomized controlled trial was undertaken to determine whether oral RA supplementation [200 mg (n = 10) or 50 mg (n = 9)] is an effective intervention for patients with seasonal allergic rhinoconjuctivitis. The patients recorded their symptoms daily in a diary card, and profiles of infiltrating cells, concentrations of eotaxin, IL-1β, IL-8, and histamine in nasal lavage fluid, as well as serum IgE concentrations, were measured. The authors found that RA supplementation resulted in a significant increase in responder rates for itchy nose, watery eyes, itchy eyes, and overall symptoms (p < 0.05). Additionally, the treatment significantly decreased the numbers of neutrophils and eosinophils in nasal lavage fluid, compared to placebo supplementation. Patients reported no adverse events, and no significant abnormalities were detected in routine blood tests [189] . [190] . In a crossover design, a PK study with six healthy male volunteers with a 10-day washout period between the administration of P. frutescens extract in a tablet containing 20 % RA and placebo was carried out. The authors found that RA reached a maximum concentration in plasma after 0.5 h, followed by a gradual increase in the plasma concentration of methyl-RA, which reached a peak by 2 h. Approximately 75% of the total RA metabolites were then excreted in the urine within 6 h. These results showed that RA contained in P. frutescens extract was rapidly absorbed, subsequently methylated, and then excreted in the urine, and the majority of RA and its metabolites were present in the plasma as conjugated forms. The main metabolites found in the urine after consuming P. frutescens extract were sulfoglucuronide conjugates of RA and methyl-RA, indicating that conjugation of polyphenolic substances, either by glucuronidation and/or sulfation, occurs in human tissues such as the intestine and liver [191] . In comparative studies, Nakazawa and Ohsawa [192, 193] found differences between human and rat metabolites of RA, reporting that RA may be predominantly metabolized to trimethoxycinnamic acid monoglucuronide in humans through hydrolytic cleavage in the gut, whereas in rats, RA is mainly metabolized to sulfated forms of trans-caffeic, ferulic, and m-coumaric acids.
Pharmacokinetics in Humans
Pharmacokinetics in Animals
!
Pharmacokinetic studies have been conducted in rats. Azevedo et al. showed that RA can modulate the transit of the intestinal Na+/glucose cotransporter-1 (SGLT-1) to the brush-border membrane, an effect that may contribute to the control of plasma glucose levels in diabetic rats [194] . Additionally, Debersac et al.
showed that supplementation of a rat diet with 0.5 % RA for 2 weeks did not increase the liver cytochrome P450 enzyme levels [195] . Konishi et al. compared PK parameters of caffeic acid and RA after oral administration in rats, indicating that the absorption efficiency of caffeic acid was higher than that of RA, and that the conjugation of both compounds occurs during permeation across the rat epithelium [196] . These findings are in accordance with Baba et al., which demonstrated that RA was rapidly absorbed (plasma values ca. 5 µmol/L) and metabolized into conjugated and/or methylated forms, and a large amount of the absorbed RA was degraded and metabolized as conjugated forms of caffeic, ferulic, and m-coumaric acids [197] . Two studies on the development of the LC-MS/MS method and its application to PK studies of RA in rats found similar values for RA PK parameters, such as C max (48.67 ± 11.24 [198] and 37.19 ± 13.85 ng/mL [199] ) and T max (1.08 ± 0.38 and 0.74 ± 0.12 h [199] ), despite using different mathematical methods and doses. In [198] , Drug and Statistics (DAS) 2.0 software (non-compartmental), and in [199] , the practical pharmacokinetic program version 87 (3P87) (survival square sum) were used, with a single administration of Herba Isodi Rubescentis extract containing RA 2.55 mg/kg in [198] , and in [199] , a mixture of the standards in saline, with RA at 6.39 mg/kg.
Pharmaceutical Development
!
Focusing on the potential antioxidant activity of RA, technological studies were conducted with the aim of improving stability and bioavailability, and verifying antioxidant interactions. The incorporation of RA into formulas as an active component was al-so proposed. In order to overcome the limitations of RA for cosmetic purposes, such as its low water solubility and discoloration, polycaprolactone microspheres loaded with RA were developed. RA-polycaprolactone microspheres with zwitterionic and nonionic surfactants presented better loading efficiency when 10 mg of RA was incorporated. The microspheres showed better long-term stability in a cream formulation compared to RA alone [200] . In another study, solid lipid nanoparticles loaded with RA were prepared with the same objectives, resulting in better stability, which can be useful for applications in the food industry [201] . Also with the aim of increasing stability and water solubility, the cyclodextrin (β-CD) complexation of RA improved the properties and antioxidant capacity [202, 203] . To study the interactions with α-tocopherol, the antioxidant efficiency of RA and RA-esters in oil-water emulsions was measured. All combinations resulted in improved antioxidant activity when compared to isolated compounds, since the concentrations were higher, and the combination of α-tocopherol and RA presented a synergistic effect. According to the authors, the formation of caffeic acid from RA in the presence of α-tocopherol occurred, and this conversion provided additional antioxidant outcomes [204] . RA proposed as an active compound against Acne vulgaris has been incorporated in a niosomal gel tested in vivo (Swiss albino mice). Both plain and niosomal formulations inhibited inflammation, and only the niosomal gel reduced the bacterial multiplication rate 4 days after application, due to prolonged release [205] . Also, considering the anti-inflammatory potential of RA, a preparation of a polygalacturonic/RA biodegradable membrane was developed to prevent postoperative abdominal adhesion, and was evaluated in vitro and in vivo. The authors demonstrated that this membrane could effectively inhibit adhesion as well as acute and chronic inflammation in rats [206] . Focusing on the construction of biosensors with high analytical performance, RA was used as a model for the quantification of pharmaceutical samples in an optimized biosensor synthetized with gold nanoparticles in an ionic liquid phase, supported in a biopolymeric matrix. The developed biosensor offered good precision and accuracy for the determination of RA [207] . In another study, RA was used to generate and stabilize gold and silver nanoparticules, acting as an appropriate antioxidant, being able to reduce the metallic ions, and also acting as a surface-passivation agent [208] .
Concluding Remarks
! RA is a natural metabolite that has attracted the interest of researchers in various areas of knowledge due to its abundance and potential biological properties. Analytical, biological, and technological RA data are compiled here for the first time.
It has served as a model for a series of scientific proposals, and will continue to be a target of investigations and the production of knowledge. There is still much that needs to be done to ensure the data from nonclinical to clinical trials are translated into meaningful knowledge. There is a lack of connectivity between studies, and many gaps are yet to be filled in order to authenticate the role of RA in human health. In future investigations covering RA, translational research should be accomplished: the application of the findings generated during laboratory or preclinical research to the development of trials and studies in humans, furnishing promising new treatments with practical applications.
Methodology ! Relevant articles from the literature were collected by searching the main scientific databases including Pubmed, Scopus, Scifinder, Web of Science, and Science Direct from 1990-2015, limiting the search to the occurrence of the keywords "Rosmarinic acid" in the title. This preliminary search identified more than 800 articles, which after the initial screening and removal of duplicates was refined, resulting in 281 articles that were scrutinized to compose this review.
